Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 1: Variations in drug prescribing;Comportement prescripteur des médecins en soins de santé primaires à Riyadh (Arabie saoudite). Examen des publications, première partie: Variations dans la prescription de médicament

Eastern Mediterranean Health Journal

Volumn 17, Issue 2, 2011, Pages 126-131

  Neyaz, Y ^a   Qureshi, N A ^a   Khoja, T ^b   Magzoub, M A ^c   Haycox, A ^c   Walley, T ^c  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b Ministry of Health ^*

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; BENZODIAZEPINE DERIVATIVE; CARDIAC GLYCOSIDE; PARACETAMOL; THIAZIDE DIURETIC AGENT;

ANTIBIOTIC RESISTANCE; DRUG CHOICE; DRUG COST; DRUG INDUSTRY; DRUG SAFETY; DRUG USE; HUMAN; MEDICATION ERROR; MEDLINE; PATIENT EDUCATION; PEER REVIEW; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY HEALTH CARE; PUBLIC HEALTH SERVICE; RESPIRATORY TRACT INFECTION; REVIEW; SAUDI ARABIA; SOCIAL STATUS; SYSTEMATIC REVIEW; TREND STUDY;

EID: 79952160325     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2011.17.2.126     Document Type: Review

References (61)

1. Bradley CP. Decision making and prescribing patterns-a literature review. Family Practice, 1991, 8:276-287.
2. Al-Nasser AN. Prescribing patterns in primary health care in Saudi Arabia. Annals of Pharmacotherapy, 1991, 25:90-93.
3. Gilleghan J. Prescribing in general practice. Occasional Papers London: Royal College of General Practice, 1991; 54:18-35.
4. Felimban FM. The prescribing practice of primary health care physicians in Riyadh city. Saudi Medical Journal, 1993, 14:335-338.
5. Khoja TA et al. Quality of prescribing at primary care centres in Saudi Arabia. Journal of Pharmacy Technology, 1996, 12:284-288.
6. Bawazir S. Prescribing patterns of ambulatory care physicians in Saudi Arabia. Annals of Saudi Medicine, 1993, 13:172-177.
7. Hogerzeil H et al. Impact of an essential drug program on availability and rational use of drugs. Lancet, 1989, 333:141-142.
8. Dizwani A et al. Morbidity patterns and prescribing habit in Harare primary care clinics. Family Practice, 1985, 2:82-85.
9. Krishnaswamy K, Dinesh K, Radhaiah R. A drug survey-percepts and practices. European Journal of Clinical Pharmacology, 1985, 29:363-370.
10. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for non-scientific prescribing. Social Science and Medicine, 1989, 28:577-582.
11. Annual health report. Riyadh, Saudi Arabia, Ministry of Health, 1999.
12. Taylor D. Prescribing in Europe-forces for change. British Medical Journal, 1992, 304:239-242.
13. Wilkie P et al. Prescribing at the hospital general practice interface. In: Hospital outpatient dispensing policies in England. British Medical Journal, 1992, 304:29-31.
14. Hemminki E. Review of literature on the factors affecting drugs prescribing. Social Science and Medicine, 1975, 9:111-115.
15. Renieri A, Piperno A. Factors affecting list size of general practitioners and number of drugs prescribed: findings of a recent study. Social Science and Medicine, 1983, 17:335-341.
16. Al-Abbasi H. Drug utilization study: Prescription patterns and patient level of comprehension in Jeddah, Saudi Arabia [Doctor of Public Health thesis]. Department of Public Health, Tulane University, New Orleans, USA, 1986.
17. Soumerai SB, Lipton HL. Evaluating and improving physician prescribing. In: Strom BL, ed. Pharmacoepidemiology, 2nd ed. New York, John Wiley, 1994.
18. Raisch D. A model of methods for influencing: Part 1. A review of prescribing models, persuasion theories, and administrative and education methods. DICP: the Annals of Pharmacotherapy, 1990, 24:417-421.
19. Tabbara K, Frayha H. The use and abuse of antibiotics. Annals of Saudi Medicine, 1996, 16:495-496.
20. Sandars J, Esmail A. The frequency and nature of medical error in primary care: understanding the diversity across studies. Family Practice, 2003, 20:231-236.
21. Neyaz Y et al. Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011, 17(2):149-155.
22. Khoja T et al. Medication errors in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011, 17(2):156-169.
23. Magzoub MA et al. Determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011, 17(2):160-166.
24. Neyaz Y et al. Predictors of quality of medication prescribing in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011, 17(2):167-171.
25. Qureshi NA et al. Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 2011, 17(2):172-179.
26. Khoja T et al. Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 2: rational prescribing. Eastern Mediterranean Health Journal, 2011, 17132-139.
27. Qureshi NA et al. Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 3: prescribing errors. Eastern Mediterranean Health Journal, 2011, 17(2):140-148.
28. Goosens H et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 2005, 365:579-587.
29. Guglielmo L et al. Antimicrobial drug utilization in Italy and other European countries. Infection, 1994, 3:S176- S181.
30. Walley T, Mossialos E. Financial incentives and prescribing. In: Mossialos E, Mrazek M, Walley T, eds. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Milton Keynes, UK, Open University Press, 2004.
31. Jeantaud I, Haramburu F, Begaud B. Consommation de benzodiazepines: enquete aupres de pharmaciens d'officine en aquitaine. [Benzodiazepine consumption: survey of community pharmacies in Aquitaine.] Therapie, 2001, 56:415-419.
32. Walley T, Mrazek M, Mossialos E. Regulating Pharmaceutical Markets: improving efficiency and controlling costs in the UK. International Journal of Health Planning and Management, 2005, 20:375-398.
33. Garattini S. Pharmaceutical prescriptions in Italy. International Journal of Technology Assessment in Health Care, 1995, 11:417-427.
34. Gross FH. Drug utilization data in risk/benefit analyses of drugs-benefit analysis. Acta Medica Scandinavica, 1984, 683:S141-S147.
35. Sunol R, Abello C, Cels IC. Studies in utilization of drugs: a review of different methods. Quality Assurance in Health Care, 1991, 3:63-72.
36. Walley T. Therapeutic conservatism. Journal of the Royal College of Physicians of London, 1994, 28:86-87.
37. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet, 2001, 357:1851-1853.
38. Walley T et al. Variations and Increase in use of statins across Europe: data from administrative databases. British Medical Journal, 2004, 328:385-386.
39. Feely J, Barry M. Adverse drug interactions. Clinical Medicine (London, England), 2005, 5:19-22.
40. Walley T et al. Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe. European Journal of Clinical Pharmacology, 2004, 60:503-511.
41. Ibrahim JE, Majoor JW. Quality, adverse events and research. International Journal for Quality in Health Care, 2000, 12:357-358.
42. McGavock H. Some patterns of prescribing by urban general practitioners. British Medical Journal, 1988, 296:900-902.
43. Majeed A et al. Prescribing of antibiotics and admissions for respiratory tract infections in England. British Medical Journal, 2004, 329:879.
44. Majeed A et al. Prescribing of lipid regulating drugs and admissions for myocardial infarction in England. British Medical Journal, 2004, 329:645.
45. Unsworth L, Walley T. Trends in primary care antibiotic prescribing in England 1994-1998. Pharmacoepidemiology and Drug Safety, 2001, 10:309-314.
46. Wilson R et al. Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices. British Medical Journal, 1996, 313:595-599.
47. Gill PS, Dowell A, Harris CM. Effect of doctors' ethnicity and country of qualification on prescribing patterns in single handed general practices: linkage of information collected by questionnaire and from routine data. British Medical Journal, 1997, 315:1590-1594.
48. Allery LA, Owen PA, Robling MR. Why general practitioners and consultants change their clinical practice: a critical incident study. British Medical Journal, 1997, 314:870-874.
49. Prosser H, Walley T. Understanding why GPs see pharmaceutical representatives: a qualitative interview study. British Journal of General Practice, 2003, 53:305-311.
50. Sebaie Z, Millier D. BaAgail H. A study of three health centres in rural Saudi Arabia. Saudi Medical Journal, 1980, 1:197-202.
51. Al-Abbassi HM, Madani KA. A survey of outpatient prescriptions dispensed in Saudi Arabia. Australian Journal of Hospital Pharmacy, 1987, 7:211-212.
52. Bawazir SA. Prescribing pattern at community pharmacies in Saudi Arabia. International Pharmacy Journal, 1992, 6:222-224.
53. Al-Dawood K. Evaluation of drug prescribing habits in a postgraduate teaching set-up in Saudi Arabia. Journal of Family and Community Medicine, 1995, 2:41-45.
54. Balbaid OM, Al-Dawood KM. Assessment of physicians' prescribing practices at Ministry of Health hospital in Jeddah city, Saudi Arabia. Saudi Medical Journal, 1998, 19:28-35.
55. Qureshi NA et al. Psychotropic drug prescriptions in primary care and general hospitals, in Saudi Arabia. Saudi Pharmaceutical Journal, 2001, 9:193-200.
56. Al-Ghamdy YS et al. A descriptive study of psychotropic drugs prescriptions in Al-Qassim region, Kingdom of Saudi Arabia. Saudi Pharmaceutical Journal, 1999, 7:44-49.
57. Al-Khaja KA, Al-Ansari TM, Sequeira RP. An evaluation of prescribing errors in primary care in Bahrain. International Journal of Clinical Pharmacology and Therapeutics, 2005, 43:294-301.
58. Moghadamnia AA, Mirbolooki MR, Aghili MB. General practitioner prescribing patterns in Babol city, Islamic Republic of Iran. Eastern Mediterranean Health Journal, 2002, 8:550-555.
59. Otoom S et al. Evaluation of drug use in Jordan using WHO prescribing indicators. Eastern Mediterranean Health Journal, 2002, 8:537-543.
60. Al-Freihi H et al. Potential for drug misuse in the eastern province of Saudi Arabia. Annals of Saudi Medicine, 1987, 7:301-305.
61. Al-Faris EA, Al-Taweel A. Audit of prescribing patterns in Saudi primary health care: what lessons can be learned? Annals of Saudi Medicine, 1999, 19:317-321.